Drug Trial Radar · NCT03548194
A Study of BNC210 in Elderly Patients With Agitation
Last checked: Nov 19, 2026Latest source record: Jul 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
38
Actual
Start
May 17, 2018
Primary completion
Apr 23, 2019
Study completion Apr 24, 2019
Sponsor
- Lead sponsor
- Bionomics LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jun 7, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase II randomised, double-blind, placebo-controlled study assessing the effects of BNC210 on agitation in hospitalised elderly patients as measured by the Pittsburgh Agitation Scale (PAS). Safety and tolerability of BNC210 will also be assessed. The secondary objectives of the study include evaluation of the effects of BNC210 on global function in patients with agitation as assessed by the Clinical Global Impression Scale (CGI-S/I). Participants will receive 5 days of blinded treatment followed by 2 days of follow up.
Conditions
- Agitation in the Elderly
Interventions
BNC210Drug
BNC210 300 mg b.i.d
PlaceboDrug
Placebo b.i.d.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute change in agitation, as measured by the Pittsburgh Agitation Scale (PAS).Time frame: 5 days
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Prince of Wales Hospital
Sydney, New South Wales, Australia
Modbury Hospital
Adelaide, South Australia, Australia
Northern Health
Melbourne, Victoria, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
Western Health
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.